Zeyue Capital
3
31M
3
1
- Areas of investment
Summary
We can highlight the next thriving fund investment areas, such as Medical, Cloud Data Services. Among the various public portfolio startups of the fund, we may underline Rimag Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The usual cause for the fund is to invest in rounds with 6 partakers. The meaningful sponsors for the fund in investment in the same round are Neovision Capital, Huayu Rongchuang, Huaxin Century Investment Group. In the next rounds fund is usually obtained by PICC Asset Management, CICC.
The usual things for fund are deals in the range of 50 - 100 millions dollars. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2018.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 1
- Investments by industry
- Medical (2)
- Information Technology (1)
- Cloud Data Services (1)
- Health Care (1)
- Pharmaceutical (1) Show 2 more
- Investments by region
-
- China (3)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Ceram Pharmaceuticals | 04 Jan 2022 | Biotechnology, Genetics, Medical, Pharmaceutical | Early Stage Venture | 30M | Shenzhen, Guangdong, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.